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Abstract:
Endothelial and smooth muscle cells are the core of the vascular system. Vessels are
created and repaired through the processes of angiogenesis and arteriogenesis. Endothelial
cells are the initial cells that migrate and proliferate during the process, followed by smooth
muscle cell movement and differentiation. The recruitment of smooth muscle cells is not
fully understood, and if understood would unlock a crucial step in the growth and
remodeling of vessels.
Endothelial and smooth muscle cells have been extensively studied in two
dimensional models and the physiologic factors that affect their function and survival have
been well documented. In living organisms, vascular tissue, consisting primarily of
endothelial and smooth muscle cells, grows in three dimensions where it is constantly
exposed to biochemical and biomechanical stimuli. Thus, a controllable three dimensional
environment is desired to study these interactions. The cells do not move instantaneously or
in direct paths, hence, it is beneficial to be able to study the cells at multiple time points and
over long periods of time. Most in vitro studies have not been conducted for more than 100
hours, while in vivo experiments have been continued for months. To fully understand in
vitro growth of smooth muscle cells, the growth should be monitored continually and the
observation technique must be able to support to this.
Accordingly, we have developed a microscope stage environmental chamber that
houses a three dimensional bioreactor for vascular tissue engineering in order to monitor
tissue function in real-time. We have demonstrated the capabilities of the environmental
control chamber by growing smooth muscle precursor cells (10Tl/2 cells) in the three
dimensional bioreactor and monitored the cells for growth, migration and proliferation.
Critical to the chamber design was the control of temperature, carbon dioxide concentration,
and humidity.
Furthermore, smooth muscle precursor cell (10T1/2 cell) migration and morphology
was observed in response to varying concentrations of Platelet Derived Growth Factor-BB
(PDGF-BB), an endothelial cell-derived growth factor that is important for smooth muscle
recruitment to remodeling blood vessels. Using a migration assay technique that observes
the general trends of cell movement through the device, the cells exposed to PDGF-BB have
been noted to move more than the cells grown in media without a growth factor. The cells
tend to migrate towards the PDGF-BB with great variability.
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Chapter 1: Introduction
1.1 Vascular formation and remodeling
Endothelial and smooth muscle cells are the core of the vascular system. Vessels are
created and repaired with these two cell types through normal and pathological processes of
angiogenesis and arteriogenesis. These two processes are crucial to the growth and
sustainability of the body. The cells and mechanisms involved have been studied in depth,
but are not fully understood. Mural cells, the precursors to smooth muscle cells, are
recruited to cover a preexisting network of endothelial cells created during angiogenesis.
The differentiated mural cells, or smooth muscle cells, cover the structure with a muscular
coat, giving the vessel its viscoelastic properties, structural integrity, and ability to constrict
or dilate. A depiction of the layers of a vessel can be found in Figure 1. The environment in
which these cells thrive and function continues to be studied in the context of vascular tissue
engineering. Signaling molecules, such as growth factors, and mechanical forces are critical
for determining these cellular functions. 1
Figure 1: Depiction of the cellular structure of the vein and artery.
Endothelial cells recruit and differentiate smooth muscle precursor cells during
vessel maturation and remodeling through signaling pathways involving growth factors such
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as Platelet Derived Growth Factor 3 (PDGF-3) and Transforming Growth Factor 13 (TGF-
3).2 Different biochemical and biomechanical cues control different aspects of vessel
development and both endothelial and smooth muscle cells are involved in the process. In
the specific case of arteriogenesis, arterial obstruction caused by a stenosis leads to an
increase in the pressure gradient across the existing collateral vessels both because of the
increased local resistance and peripheral vasodilation. This increase in pressure drives an
increase in flow and consequently the wall shear stress which activates endothelial cells and
recruits smooth muscle cells. The vessel enlarges, initially due to smooth muscle relaxation,
but later due to active remodeling of the extracellular matrix and smooth muscle cell
recruitment. If the fluid shear stress is reduced, the reverse process takes place and vessels
narrow. Several endothelial and inflammatory cell factors have been associated with the
optimization of this process,3 but the process of collateral vessel development remains
poorly understood.
Previous research that combines smooth muscle and endothelial cells has primarily
been done in two dimensions. Smooth muscle cells and their precursor cells, 10T1/2 cells,
have been grown on multiple 2D sandwich structures of collagen combined with endothelial
cells. In the presence of endothelial cells, 10T1/2 cells migrate towards the endothelial cells,
and when there is physical contact between the cells, the 10T1/2 cells differentiate into
smooth muscle cells.4 Smooth muscle cells and endothelial cells have also been studied
under shear stress in a two-dimensional environment. The migration of the smooth muscle
cells increases until the shear stress reaches 1.5 Pa. After this point, the cell migration is
halted and is less than the control rate of migration. This suggests a direct relationship
between stress and the remodeling of vessels.s These 2D experiments, however, are a poor
representation of the true 3D environment in which these processes occur in vivo. For this
reason, we have developed a 3D system that more realistically portrays in vivo conditions.
1.1.1 Three dimensional platform for studying vascular formation
It is now widely recognized that most cell types function differently in three
dimensional environments compared to two dimensional environments. Accordingly, the
vascular research conducted in the Center for Biomedical Engineering is primarily done
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using 3D scaffolds contained in a polydimethylsiloxane (PDMS) micro fluidics bioreactor.
With this system, the surface shear stress, as well as the pressure difference and biochemical
gradient across the cell matrix can be controlled. Recent work has shown that endothelial
cells grown in the bioreactor organize into capillary-like structures which suggest the
initiation of the neovascularization processes.6 To further study angiogenesis, smooth
muscle cells must be incorporated into the bioreactor system. Thus, the goal of this thesis is
to mimic the in vivo vascular remodeling function of smooth muscle cell migration in a 3D
environment and develop the technology needed to view this growth in real-time.
Mesenchymal precursor cells, 10T1/2 cells, were grown in a three-dimensional
collagen matrix. The three-dimensional bioreactor developed for endothelial cell growth by
V. Vickerman was used for the present 10T1/2 cell experiments. Cell morphology and
migration were observed in response to different doses of PDGF-BB. PDGF-BB was
chosen as the growth factor to use because studies show that both smooth muscle precursor
and smooth muscle cells are stimulated to migrate by endothelial cell media and specifically
PDGF-BB. When the PDGF-BB action is blocked in 10T1/2 cells with neutralizing
antibodies, the migration and proliferation increase that is observed with endothelial cell co-
culture is not observed.4 These studies were conducted in vitro, and similar results are found
in vivo. Mice that are PDGF-B receptor deficient have leaky and abnormal vessel
formation.7 10Tl/2 cell proliferation and migration, as observed by others, increases in a
dose-dependent manner, which is why this study uses multiple conditions to test the
migration of the 10T1/2 cells.4 ' 8
The analysis of chemical gradients and penetration of signals in a unique three-
dimensional environment is an important step in understanding neovascularization. A
chemical gradient of PDGF-BB is set up across the 10Tl/2 cell scaffold and migration is
observed in real-time. Currently, the cells in the bioreactor are grown in an incubator and
need to be removed for observation. To understand the full scope of smooth muscle cell
proliferation and migration, the cells need to be viewed in real-time.
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1.2 Bioreactor and Bench-top Incubator Device Design
The current bioreactor, made of PDMS gel, is pictured in Figure 2 and the bioreactor
design is depicted in Figure 3. Cells are introduced either by being transported in the
channels of the bioreactor (through the connector ports in Figure 3) or injected directly into
the collagen before it has hardened.
A B
Figure 2: PDMS gel: channels are clearly visible in A and size comparison in B.
/
Scaffold "cage"Connector
Ports
Media
Channels
A B
Figure 3: Bioreactor design: A) Media channels and connector ports B) Larger scale view of collagen
scaffold, black depicts media channels, gray - collagen scaffold, white - PDMS gel.6
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After the cells have been placed in the collagen gel, the PDMS bioreactor is placed
in a clamp. The clamp is depicted in Figure 4. The connector ports of the bioreactor are
connected to media flow. The bioreactor and clamp is then placed in an incubator. The
clamp was originally used as a way to hold the bioreactor in place while fluid was flowed
through the device.
Figure 4: The bioreactor is placed in the clamp base (left) and the top (right) is inverted and clamped
on top
Different growth factors can be circulated through the media channels in the system
to achieve a chemical gradient in the collagen scaffold. Currently, in order to image cells at
different time-points throughout an extended experiment, the device must be removed from
the incubator and placed under a microscope. The cells cannot survive outside the incubator
for long periods of time at room temperature and low humidity; therefore, observation time
must be kept short. Because of this, the clamp was integrated into a custom-designed
climate controlled incubator, so that the clamp can be kept on the bench-top and the cells
can be viewed in real-time.
The incubator device includes heat coils, a temperature sensor, and a carbon dioxide
transport system. This system makes it possible to grow smooth muscle cells and view them
on the microscope stage. The effect of chemicals and environmental control changes can be
seen instantaneously because of the ease of real-time viewing of the sample. Further
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applications of the bench-top incubator include growing endothelial cells and smooth muscle
cells simultaneously in the bioreactor. The interaction between the cells and the eventual
capillary-like formation can be viewed continuously, providing a powerful tool for studying
new vessel formation.
Such a bench-top vascular system has broader usefulness for pharmaceutical
development and drug testing. Companies could theoretically be able to perform the first
round of product testing on in vitro capillaries instead of solely using endothelial and
smooth muscle cells in 2D. The changes to the cells due to the tested products could be
observed immediately using the real-time viewing capabilities of the bench-top incubator
device and would eliminate the need for animal models in the early stages of testing.
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Chapter 2: Methods
Smooth muscle precursor (10T1/2) cells were used in the experiments. A migration
assay for both 2D and 3D cell growth was developed and used to quantify the movement of
cells in response to the addition of PDGF-BB. The cells were grown in both 2D and 3D. The
results of the thesis focus on the cell growth in 3D, but the 2D growth was needed to
understand and optimize the growth of the 10T1/2 cells. The details of the cell growth
protocols and the experimental techniques used are noted below.
2.1 Cell Growth
10T1/2 cells (CCL-226, ATCC, Manassas VA) passages 9-11 were used in all
experiments. When cultured for three days prior to device injection, the cells were grown on
Collagen (50 ug/mL Type 1 collagen in 0.02N acetic acid) or Gelatin (0.1%) in DMEM
growth media (Dulbecco's Modified Eagle Medium with 4.5 g/L D-Glucose, and L-
glutamine, without Sodium Pyruvate (Invitrogen, Grand Island, NY), with 10 % Fetal
Bovine Serum (Cambrex Bio Science, Walkersville, MD), and 0.5% Penicillin
streptomyosin))
2.1.1 Passage Protocol
The media was aspirated and the cells were rinsed twice with 1 mL warmed PBS
(Dulbecco's Phosphate Buffered Saline, IX, without Calcium Chloride or Magnesium
Chloride (Invitrogen, Grand Island, NY.)) The PBS was aspirated and 1 mL warm trypsin
(0.05% trypsin- EDTA, 1X, Invitrogen, Grand Island, NY) was added. The flask was placed
in the incubator for 1 min or until the cells had detached from the flask. 4 mL growth media
was added and the mixture was centrifuged at 1000 RPM for 5 min or until a pellet formed.
The media was aspirated and the pellet was resuspended in 12 mL growth media. 4 mL
media with cells was transferred to each of the three newly coated culture flasks.
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2.1.2 Culture Flask Coating
Collagen
1 mL Type I collagen solution (50 ug/mL Type 1 collagen in 0.02N acetic acid) was
added to the cell culture flask and incubated for 2 hours. The excess collagen was aspirated,
and the flask was rinsed twice with 1 mL warmed PBS without Calcium and Magnesium.
Gelatin
4 mL gelatin solution (0.1%) was added to the cell culture flask and incubated for 15
min at room temperature. The excess gelatin was aspirated, and the flask was rinsed twice
with 1 mL warmed PBS without Calcium and Magnesium.
2.1.3 Freezing Protocol
The cells were grown from passage 5 to passage 10 and then frozen. The cells were
thawed two days before each experiment. The cells were frozen after being passaged.
Instead of resuspending the cells in regular growth media, the cells were suspended in 1 mL
FBS with 5% DMSO and placed in cryogen tubes. The cells were kept in liquid nitrogen.
2.2 Fluorescence Staining
The cells were fluorescently stained before they were used in the devices. (PKH26
Red Fluorescence Cell Linker Mini-Kit, Sigma- Aldrich Inc., St. Louis MO)
The cells in the culture flask were rinsed in serum free media (Dulbecco's Modified
Eagle Medium with 4.5 g/L D-Glucose, and L-glutamine, without Sodium Pyruvate
(Invitrogen, Grand Island, NY) and with 0.5% Penicillin streptomyosin).
2 mL 2.5 x 106 M PKH26 Red Fluorescence Cell Linker (5tl of 1 x 106 M Pkh26
Linker in Ethanol and 1.995 mL Dilutant C) was added to the cells and incubated for 6 min
at room temperature. 2 mL FBS was added and the cells were incubated for another minute.
The cells were rinsed three times and resuspended with regular growth media.
The cells fluoresce for more than five days with minimal photo bleaching.
2.3 PDGF-BB
The PDGF-BB (recombinant mouse platelet-derived growth factor-BB (BioSourse
International, Camarillo, CA)) was diluted into 5 ug/mL or 100 ug/mL aliquots and stored in
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20 and 50 uL stock supplies until the day of the experiment. The aliquots were prepared by
reconstituting 10 ug of PDGF-BB in 100 mM acetic acid (99% pure, Sigma- Aldrich inc., St.
Louis MO)) and 0.1% BSA (Albumin, Bovine Serum Fraction V, Crystalline, CalbioChem)
The stock was diluted in growth media to concentrations of 5, 7.5, 10, and 50 ng/mL
in 2% FCS growth media.
2.4 Migration Assay
The cells were plated in C6 plates at a concentration of 125,000 cells per well. They
were grown over night or until confluent and scratched with a 1 mL pipette tip to create a
gap in the cell layer. The gap was approximately 700 - 1100 um in width.
In one trial, 2% FBS growth media was added to three of the wells and 2% FBS
growth media with 5ng/mL PDGF was added to the other three. The scratch width was
reported at 5, 12 and 24 hrs, and the average migration per hour was calculated. The cells
were rinsed twice with PBS with Calcium and Magnesium (BioWittaker, Walkersville MD)
before the media was added.
In the second test, the above experiment was repeated with 7.5ng/mL PDGF,
10ng/mL PDGF, and regular 2% FBS growth media in two wells each. The results at 0 and
15 hours were compared.
2.5 Bioreactor Devices 9
2.5.1 PDMS Preparation
The SYLGARD 184 Silicone Elastomer (Daw Coming, Midland, MI) was used to
make the devices. The Base and Curing agent were mixed in a 10:1 ratio; approximately
100 mL was used for four PDMS devices. The agents were mixed together and placed in
the vacuum dessicator to remove air bubbles for 45 min. The mixture was poured onto the
silicone wafers and placed in the dessicator again for 45 min. The devices were cured
overnight in an 80 0 C oven or for two days at room temperature.
2.5.2 Device Preparation
The PDMS devices were placed in distilled water and run in the autoclave for a 20
min wet cycle. The devices were moved to a dry pipette tip box and autoclaved for 25 min
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dry cycle, 15 min dry time. The devices were then plasma-sterilized four at a time for 2.5
min.
2.5.3 Cell Implantation
20 uL PBS (10X with Phenol Red), 3.6 uL 1 M NaOH, 115 uL Type 1 collagen (3.50
mg/mL, BD BioSciences, Bedford MA), and 30 uL distilled water were mixed with 32 uL
media suspended strained cells to make the collagen-cell mixture right before the devices
were injected. The cells are at a concentration of 2x106 cells/mL in the media and the final
concentration of cells in the collagen-cell mixture is 3.2x10 5 cells/mL. 40 min after the
plasma treatment, the devices were injected with a drop of the collagen-cell mixture. The
injection set-up is seen in Figure 5
A B
Figure 5: Picture of needle and microscope: A) Microscope stage and needle B) Overall view.
Once injected, an autoclaved coverslip (35mm circular) was placed over the PDMS
device and the device was placed in a hydration box (50 mL water in a 1 mL pipette tip box,
autoclaved with the devices in the wet cycle). The collagen was cured for 40 min in the
incubator, and 70 uL of growth media was placed on each channel and 20 uL was pulled
through each channel. The media was exchanged in a similar fashion every 12 hrs during
cell observation.
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When testing the PDGF-BB, the regular growth media was replaced by 2% FBS
growth media 12 hrs after injection, and replaced by 5, 7.5, or 10 ng/mL PDGF-BB in one of
the channels 36 hrs after injection.
The devices were photographed at 4, 8, 20, 28, and 50 hrs. The images at 0, 28, and
50 hrs were superimposed and the distance traveled by the different cells was measured
using the pixval function in Matlab. The distance between the centroid of the cells is
measured in pixels and converted to um using the conversion lmm:428 pixels in 4X and
lmm:1560 pixels in 10X.
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Chapter 3: Results
3.1 Smooth muscle cell migration assay development
The goal here is to develop an assay for studying smooth muscle cell migration in
response to a number of stimuli, including growth factor stimulation and endothelial-derived
product. Initially application of PDGF-BB, a know stimulator of smooth muscle cell
migration, was used to develop the assay. First, a scratch migration assay in 2D was
conducted to test the effectiveness of PDGF-BB on the cells and determine what
concentration should be used in the devices. Since the PDGF-BB is reconstituted in acetic
acid, the higher concentrations of PDGF-BB may be toxic for the cells due to the higher
concentration of acetic acid.
The migration speeds of cells in 5 ng/mL PDGF-BB in 2% FBS and the control cells
in just 2% FBS media were compared. Pictures were taken at 0, 5, 12, and 24 hrs. The
average speed of gap closing was calculated between 5 and 12 hours after the addition of
PDGF-BB. This was done by comparing the gap size at different time points. An example
of the gap size change is seen in Figure 6.
A B
Figure 6: Cells in 2% FBS growth media at A) 5 hrs and B) 12 hours
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The average speed of the control was 52+9 um/hr and the average speed of the
PDGF-BB exposed cells was 77±5 um/hr, showing the effectiveness of PDGF-BB at 5
ng/ml for stimulating 10Tl/2 cell migration. Three trials were completed for each media
and the results can be seen graphically in Figure 7. The difference in speed is statistically
significant (p<0.05)
Mean Gap Closure Speed
VU
80
70
60
S50
=40
30
20
10
0
control 5ng/mL PDGF-BB
Figure 7: Average speed of gap closure from 5 hrs to 12hrs after cells were exposed to PDGF-BB
Once the efficacy of PDGF-BB as a stimulator of 10T1/2 cell migration in 2D was
established, the growth factor was used to stimulate migration in the 3D bioreactor. First, an
understanding of the growth factor gradient across the gel scaffold region must be achieved.
The PDGF-BB concentration across the collagen scaffold reaches steady state after 3 hours.
The diffusion coefficient of PDGF-BB in collagen is estimated to be 1x10-10 m2/sec. 10
Using Equation 1; the time it takes to reach steady state is calculated.
12
t =-- (1)
D
Where 1 is the width of the collagen scaffold, 1 mm, and D is the diffusion
coefficient of PDGF-BB. Furthermore, the gradient of PGDF-BB throughout the collagen
matrix is linear at steady state. The initial concentration of PDGF-BB in one channel and the
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control media is the other are assumed to have an infinite supply, representing a constant
flux at each boundary.
Next, the 3D collagen gel scaffold-cell mixture and the injection technique were
optimized for smooth muscle cells since the original bioreactor and protocol were designed
for endothelial cells. The optimization is discussed in Chapter 4.
Once the cell growth in 3D was successful, the 10Tl/2 cells were stained with a
fluorescent live cell tracker and imaged at 0, 4, 8, 21, 28, and 50 hours at 4X and 10X. The
images from 0, 28, and 50 hours were superimposed to make the movement of the cells
quantifiable.
An example of the difference between bright field and fluorescence along with the
superposition of the fluorescence images from the different time points can be seen in Figure
8 for a control device containing no growth factor stimulation.
.thrs
28WTs
V
Figure 8: Bright field and fluorescent superposition of different time points of two different control
devices (2%FBS growth media in both channels)
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A similar set of images for the 5
shown in Figure 9.
ng/mL PDGF-BB in 2 % FBS growth media are
Red- Ohrs
Green-28hrs
Blue- 50hrs
Figure 9: 5 ng/mL PDGF-BB in lower channel. 0, 28hrs, 50 hrs
images superimposed.
bright field images and fluorescence
Some of the cell movements were quantified from the 10X, but no conclusions could
be drawn from the data. An example of cell movement can be seen in Figure 10. The PDGF-
BB is applied on the bottom of the device, and the cells seem to be moving towards the
PDGF-BB.
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Red- Ohrs
Green-28hrs
sive .0w.
Figure 10: 7.5 ng/mL PDGF-BB in lower channel. 0, 28hrs, 50 hrs fluorescent images have been
superimposed.
The marked cells have moved 140 um and 90 um. There were not many devices with
such well defined movement as in this image; therefore, to quantify the movement of the
cells, the fluorescent images of the devices in 4X were divided into a top and bottom
section. At each time point, the amount of cells in each section was counted and normalized
as a proportion to the total number of cells in the device. A picture of how the device was
sectioned is seen in Figure 11.
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Figure 11: Diagram of how the cells were counted
This was repeated for each concentration of cells at 0, 28, and 50 hrs. The data
suggest cell movement towards the PDGF-BB. The cells in the control do not move while
there is much movement in the devices with PDGF-BB. A diagram of the percent change in
the half of the device closest to the PDGF-BB over 28 hours is seen in Figure 12. The
PDGF-BB was applied to the bottom of the devices; hence, a change in cell proportion
towards the 'Bottom' suggests the movement of cells towards the PDGF-BB.
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Percentage of 10T1/2 cells migrating along PDGF-BB gradient in
3D after 28 hours (N=2)
20
15
10
5
0
control 5 ng/ml 7.5 ng/ml 10 ng/ml 50 ng/ml
Average for each concentration
Figure 12: Percent increase with error bars in the number of cells in the section close
over a span of 28hrs for 0, 5, 7.5, 10, and 50 ng/mL concentrations
to PDGF-BB
The cells were also counted trying to capture the cell movement in the different areas
of the PDGF-BB gradient. The cells were counted similarly to Figure 11, but each top and
bottom section was split up in two portions. This way, the cell movement across four
sections was analyzed. The graph of this data is seen in Figure 13.
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Percentage of 10T1/2 cells migrating along PDGF-BB gradient in
3D after 28 hours (N=2)
15
10
5
0
-5
-10
-15
control 5 ng/ml 7.5 ng/ml 10 ng/ml 50 ng/ml
Average for each concentration
9 Farthest Away from PDGF E Mid-way
U Mid-way close to PDGF RE Closest to PDGF
Figure 13: Percent increase in number of cells across the PDGF-BB gradient over a span of 28hrs for
0, 5, 7.5, 10, and 50 ng/mL concentrations
The distinct movement that would be expected is seen in the 50 ng/mL device. There
are a decreased percentage of cells in the two top sections, and an increased percentage of
cells in the sections closest to the PDGF-BB. The data is clearer and less variable in the
initial assay analysis using two sections than in this analysis method.
3.2 Bioreactor Bench-Top Incubator Design
In order to create a bench-top incubator, multiple designs were considered. The
current bioreactor clamp was chosen since the clamp was already designed to keep the
bioreactors in place and did so successfully. Using this as the starting point, two heat coils
(CIR Series, 120V length 2 in, 80 W, 1/4" diameter) were fit tightly on opposite sides of the
device with the thermocouple (TP30 sensor) in between them. The temperature controller
(5C1-140 Controller, Oven Industries, PA) was used to control the heat coils. The redesign
of the top and bottom portions of the clamp is seen in Figure 14.
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A B
Figure 14: A) bottom section of clamp with holes for heat coils (with screws to push the coils snug to
the device), thermocouple, clamping mechanism, and carbon dioxide fittings. B) Top section of clamp with
holes for the clamping mechanism and side hole for carbon dioxide flow above the PDMS. "
The temperature controller does not have a built in temperature sensor readout and
required calibration in order to maintain the bioreactor temperature at 370C. A temperature
sensor was placed into a PDMS chip when it was poured, and the temperature was measured
at the center of the chip when testing the device. It was allowed to equilibrate at 360C and
the thermocouple settings were kept constant for the cell tests. An Airgas mixture (5% CO 2
and 21% 02 in a N2 cell culture balance) was slowly flowed over the devices. The gas was
bubbled through a heated water bath before entering the device to humidify the air. The
final device with PDMS temperature probe is seen in Figure 15.
Figure 15: Bench-top incubator with temperature probe in PDMS along side the temperature
controller.
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The PDMS test chip was replaced with a PDMS device with the collagen-cell
scaffold. A control was placed on the bench-top, open to the environment and one in the
regular incubator. The devices were inspected 12 hours post incubation. The cells in both
the regular incubator and the clamp incubator survived and looked healthy, while the cells
grown on the bench-top alone did not look healthy. Both the devices on the bench-top had
dried out partially though. The one in the bench-top incubator had some fluid left in the
ports while the device outside of the incubator had completely dried up. Figure 16 shows
the cells from the device that was on the bench-top alone as well as an image of the drying
out of the bench-top incubator device.
A B
Figure 16: A) Image of the device that was kept on the bench-top alone for 12hrs B) Picture of edge
of the device after being in the bench-top incubator for 12 hrs.
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A picture of the healthy cells before and after 12 hours of being in the bench-top
incubator is seen in Figure 17.
A B
Figure 17: A) 64 hrs after injection B) 98 hrs after injection and after 12 hrs of being in the bench-top
incubator.
The cells survived for 12 hours in the bench-top incubator and did not survive solely
on the bench-top.
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Chapter 4: Discussion
4.1 Smooth muscle cell migration in 3D
The cells grown in a PGDF-BB gradient migrated more than the cells grown in the
controls. In general, the cells moved towards the PDGF-BB as seen in devices of all PDGF-
BB concentrations. The most consistent results are seen in the 7.5 ng/mL devices. The cells
in the 7.5 ng/mL devices show a marked migration towards the PDGF-BB with low
variability. The cells grown in the 10 ng/mL gradient show more movement, but the
movement is more variable. The 50 ng/mL tests were expected to show either lower
variation in the data or more migration than the 10 ng/mL data, neither of which were found.
When cells were plated in 2D and grown in 50 ng/mL PDGF-BB there was tremendous
elongation and proliferation compared to the controls, however, the same result was not seen
in 3D. Cells are known to migrate much slower in three dimensions. Therefore, the fact that
the effect of PDGF-BB in 3D is not as great as in 2D is expected, yet a marked difference is
predicted. In the 50 ng/mL device test, the humidity in the incubator was low and the
devices dried out slightly over night. This could have attributed to the low migration of these
cells.
The technique developed to be able to apply a concentration gradient to the cell
scaffold is elaborate and many trials were conducted before cell survival was noted. There
are many variables that if altered slightly effect cell survival.
The syringe diameter could potentially affect the cells when they are being injected
into the device. The 2.5 uL syringe had an adequate survival rate of the cells passed through
the syringe.
Devices with different collagen percentages and cell densities were made. The cells
need to survive for over 96 hours and the collagen scaffold must be kept intact throughout
the experiment. A low concentration of collagen led to the scaffold deteriorating before the
end of the experiment while a high concentration led to higher cell death. 2% collagen, as
noted in the methods section was chosen. Cell death in the devices was approximately 25-
50%. When the devices had 20 or more cells, fluorescent imaging became easier and the
variability between cells could be accounted for. If more than 50 cells were seeded per
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device, the cells were difficult to distinguish, and the result of PDGF-BB addition could
have been confounded by cell to cell contact. The cells were diluted to 3.2x105 cells/mL in
the collagen-cell mixture that was injected into the devices.
The cross linking of collagen in the hydration box seemed to vary between each
experiment. Even with the same proportions of substances in the collagen mixture, the
degree of cross linking would vary each time. This could be due to slight inadvertent
variations in the protocol such as how long the collagen had been in the needle before
injection or how much water was in the hydration box. These changes were harder to control
or identify, but after much trial and error a consistent protocol was developed. Adhering to
the details of the protocol is important for low variability of the results.
Bubbles in the needle or in the collagen were also an issue. If bubbles were trapped
in between the PDMS and coverslip, the collagen scaffold would not be continuous in
between the posts and would deteriorate quickly. To eliminate bubbles, the needle was
rinsed multiple times until it was filled with bubble free water. The water was replaced with
collagen, and rinsed again with the collagen-cell mixture. This eliminated the bubbles in the
scaffold, and also ensured that there was no variability in the amount of potential water or
air that the cells had come in contact with before being injected into the device. The swift
placement of the coverslip over the PDMS following injection was also important. The
coverslip was simply placed on the PDMS and allowed to adhere without applying pressure.
The small differences between each device such as the ones mentioned above can
introduce variability between the samples. Any one of the changes could affect the
microstructure and mechanical properties of the collagen and in turn influence the migration
of the cells.
Another device design issue that has been addressed is that even though the cells
survived and were observed for 90 hours, after 50 hours, the glass coverslip started to detach
from the PDMS. In the detached devices, the PDGF-BB gradient could no longer be
imposed, which could have led to the cells moving without a regular pattern. This could be
due to many factors. Some potential factors were that the devices got too wet during the
collagen cross linking step and detached from the coverslip. The hydration box was wiped
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down before the devices were placed in the box to ensure that the device did not come in
direct contact with water.
The Plasma Sterilizer used to plasma treat the devices had no quantifiable way of
measuring how hydrophilic the devices were. The amount of time that the devices were
being plasma sterilized was varied between 2 and 3 minutes, 2.5 min being the most
effective time. If the cells were injected too soon after the treatment, the collagen would not
stay in the scaffold areas but would spread out into the channels. If the injection happened
too late, the PDMS would no longer be hydrophilic and the collagen would form a drop on
top of the PDMS and not spread out and into the scaffold cage. Even with consistent times
in the plasma treatment, the required waiting time before injection varied. 40 minutes was
approximately the appropriate time, but some devices were not the correct hydrophilicity
after 40 min. The variations in hydrophilicity could be dependant on the placement of the
devices in the plasma treater. No direct correlation between location and treatment strength
could be made though. As a way to try to reduce leakage, the coverslip was also plasma
sterilized. The devices that used these coverslips had patchy scaffolds, indicating that the
collagen had spread out from the scaffold cage area into either the channels or in between
the PDMS and the coverslip.
If there was an easy way to measure the hydrophilicity of the PDMS without
injecting collagen into it, all the cells could be injected using the same conditions and the
variability between devices may decrease.
Having a solid bond between the coverslip and PDMS is important in being able to
keep the concentration gradient and avoid leakage. The cells grown in 2D seemed to migrate
more quickly at least 18 hours after PDGF-BB addition. Since cells migrate slower in 3D,
longer time periods are necessary for 3D movement. If leakage could be eliminated, the cells
could be viewed for longer periods of time and more marked migration patterns may be
observed.
The 3D migration assay that was developed is a good way to observe general cell
movement. As seen in Figure 10, trying to observe movement in 10X is difficult due to the
multiple layers of cells in the 3D scaffold. There are four or five layers of cells and
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fluorescent images would need to be taken of each layer to see the full cell movement. The
amount of data that would be collected is far too large to analyze quickly.
In the 10 X images, some cells move out of sight during a series of pictures because
they move vertically in the scaffold or out of the image region. Also, if the cell density is too
high, it is hard to differentiate between cells and know which cells migrate where. Because
of this an assay that would quantify the general migration patterns of the cells was
developed.
By using a lower magnification and not requiring the tracking of individual cells, the
trends of the cells can be noted. When comparing the results of the two assays, the first one,
measuring the migration over the center boundary, shows more concrete results. When
viewing the migration split up into sections, the effect is not as well defined, and the
variation in movement is large. The second assay would yield better results if a higher
seeding density was used. In this experiment, due to the lower cell density, the variability of
the cells and human error in counting outweighed the potential benefits of being able to see
the differences in cell movement throughout the concentration gradient. The data is
promising though, and there seems to be a threshold concentration between 7.5 and 10
ng/mL. In future research, a minimum of 10 ng/mL PDGF-BB should be used to note a
change in migration of smooth muscle precursor cells in 3D.
Both assays can be used to note the migration of cells in many other chemical
gradients such as different growth factors, conditioned media, or endothelial co-culture.
Improvements can be made upon the experiments conducted. The first and foremost
being repeating the experiments. Larger sample populations are needed to make clear
statements on the effect of PDGF-BB on smooth muscle precursor cells in 3D. Each
concentration has only been tested two or three times, making none of the results in 3D
statistically significant. The trends of the cells suggest that if more trials were completed,
significance would be found.
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4.2 Bioreactor Bench-Top Incubator Design
The bench-top incubator kept the 10T1/2 cells alive for an extended period of time at
360 C. The humidity in the device was not kept high enough though, and the bioreactor dried
out in the bench-top incubator more than in a regular incubator. This could be solved by
encapsulating the bench-top incubator in a clear box with water reservoirs inside. This
would keep the whole volume at a constant humidity and still maintain the real-time viewing
capabilities of the incubator.
The size of the incubator was taken into consideration when developing the design.
Ideally multiple incubators would be on the microscope stage at the same time and would be
rotated around to take pictures of all devices consecutively. Encapsulation of the incubator
would hinder the ease with which this could be done.
The flow of the cell culture gas mixture was not kept constant throughout the trial
period of the incubator. The tank regulator flow was dependent on the amount of gas left in
the tank; hence, a flow regulator is needed to control the flow. This could also help in
keeping the humidity high. The gas is bubbled through a water bath before entering the
incubator; if the flow rate was slow enough, the flow would heat and humidify the system
instead of drying it out which probably happened during the trial.
A series of valves would allow us to regulate the flow to a low enough rate that the
volume around the device would not be displaced in less than 10 min. At this rate, the gasses
would diffuse through the PDMS, but not remove the water from the device.
The temperature controller used for the incubator does not have a temperature
readout, but has to be calibrated with a thermometer before the devices are placed in the
incubator. If the temperature varies during the experiment there would be no way of
noticing. A controller with a temperature readout is much more expensive than the current
one. The temperature readout capabilities are probably not worth the increase in price since
it would make it more difficult to make multiple incubators that run simultaneously. Having
a temperature readout would give us more control and make the cell environment less
variable though.
The basic requirements of the incubator were met and the cells survived long enough
to note the benefits of real-time viewing.
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Conclusion:
Many studies have been conducted on the migration, proliferation, and
differentiation of cells in 2D. Using the tissue engineering platform of this experiment and
the migration assay developed, the same studies can now be conducted in three dimensions,
bringing the research one step closer to mimicking in vivo function.
Smooth muscle cell research in particular can lead to the understanding of the later
steps of neovascularization. The smooth muscle precursor cells used in this experiment
migrated towards the PDGF-BB in the 3D scaffold. Experiments that would observe the
cells for longer time periods as well as experiments with more devices would probably lead
to statistically significant results.
Incorporating smooth muscle cells with endothelial cells in a co-culture in the device
would be very interesting. Observing smooth muscle precursor cells and endothelial cells
together can be done in real-time and in three dimensions when using the combined
bioreactor and bench-top incubator. The movement of the smooth muscle cells in response
to endothelial cells could be compared to the smooth muscle cell migration in response to
other growth factors or chemicals known to be involved in neovascularization. The cell co-
culture could be observed continuously using the bench-top incubator and the cell to cell
interactions could be recorded. The technique developed in this thesis is very promising as a
stepping stone to further research in mimicking the in vivo functions of the cells involved in
neovascularization.
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